NAZİK BAHÇECİOĞLU, S. Et Al. 2022. Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study. ASTIM ALLERJI IMMUNOLOJI , vol.20, no.2 , 81-86.

NAZİK BAHÇECİOĞLU, S., TURK, M., ATAYIK, E., PAÇACI ÇETİN, G., ARSLAN, B., GÜLMEZ, İ., ... YILMAZ, İ.(2022). Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study. ASTIM ALLERJI IMMUNOLOJI , vol.20, no.2, 81-86.

NAZİK BAHÇECİOĞLU, SAKİNE Et Al. "Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study," ASTIM ALLERJI IMMUNOLOJI , vol.20, no.2, 81-86, 2022

NAZİK BAHÇECİOĞLU, SAKİNE N. Et Al. "Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study." ASTIM ALLERJI IMMUNOLOJI , vol.20, no.2, pp.81-86, 2022

NAZİK BAHÇECİOĞLU, S. Et Al. (2022) . "Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study." ASTIM ALLERJI IMMUNOLOJI , vol.20, no.2, pp.81-86.

@article{article, author={SAKİNE NAZİK BAHÇECİOĞLU Et Al. }, title={Mepolizumab-Related Adverse Events in Severe Eosinophilic Asthma: A Real-Life Study}, journal={ASTIM ALLERJI IMMUNOLOJI}, year=2022, pages={81-86} }